和法论治乳腺癌内分泌治疗后类更年期综合征的疗效观察

doi:10.3969/j.issn.1671-7171.2021.09.016

Abstract
Figure/Table
References (0)
Related Citation (13)

Download: PDF (1143 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To explore the clinical effects of treating postmenopausal syndrome after endocrine therapy of breast cancer with Chinese medicine way of Hefa (harmonic herbs). 【Methods】A total of 78 patients with menopausal syndrome after endocrine therapy of breast cancer from January 2018 to January 2020 in our hospital were selected for the study. All patients were divided into the observation group and the control group by random number table method, with 39 cases respectively. The control group was treated with endocrine drugs, oryzanol tablets and vitamin B1 at the same time. The observation group was treated with traditional Chinese medicine way of Hefa (harmonic herbs) on the basis of the control group. The clinical efficacy, TCM syndrome score, serum sex hormones [estradiol (E₂), luteinizing hormone (LH), follicle stimulating hormone (FSH)], tumor markers [carbohydrate antigen 15-3 (CA15-3), carbohydrate antigen 125 (CA125)] were compared between the two groups before and after treatment. 【Results】The total effective rate of the observation group was 92.31%, which was significantly higher than 74.36% of the control group (P<0.05).There was no significant difference in TCM syndrome score between the two groups before treatment (P>0.05). After treatment, the scores of menstrual disorder, hot flashes and sweating, emotional changes, dizziness and tinnitus, waist and knee soreness, palpitation and insomnia in the observation group were significantly lower than those before treatment and after treatment in the control group, and the difference was statistically significant (P<0.05).There were no significant differences in the levels of E₂, LH, FSH, CA15-3 and CA125 between and within the two groups before and after treatment (P>0.05). 【Conclusion】After endocrine therapy of breast cancer, patients with menopausal like syndrome can be treated with traditional Chinese medicine way of Hefa (harmony) to significantly relieve the clinical symptoms of patients without significant impact on sex hormones and tumor markers.

Key words： Breast Neoplasms/PX Toremifene /TU Aromatase Inhibitors/TU CLIMACTERIC SYNDROME

Received: 08 April 2021

PACS:

R737.9

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WU Xiao-mei
	LUO He-ting
	LIU Mi-hua
	et al

Cite this article:

WU Xiao-mei,LUO He-ting,LIU Mi-hua, et al. Study on Chinese Medicine Way of Hefa (Harmonic Herbs) in the Treatment of Menopausal Syndrome after Endocrine Therapy of Breast Cancer[J]. JOURNAL OF CLINICAL RESEARCH, 2021, 38(9): 1334-1337.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2021.09.016 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2021/V38/I9/1334

[1] 李一桔, 陈云霞, 陆萍,等. 医护一体化模式对乳腺癌患者改良根治术后上肢功能训练自我效能及康复效果的影响[J].医学临床研究, 2021, 38(3):455-457.
[2] KEKLIKOGLOU I, CIANCIARUSO C, GÜÇ E,et al. Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models[J].Nat Cell Biol,2019, 21(2):190-202.
[3] 韩文鹤, 王晓彤, 陈艳丽. 乳腺癌术后接受内分泌治疗的患者发生子宫内膜癌的危险因素分析[J].医学临床研究, 2021, 38(3):428-430.
[4] 严晨, 王笑民, 于明薇,等. 乳腺癌内分泌治疗相关类更年期综合征的中医研究现状[J].中华中医药杂志, 2017, 32(10):4552-4554.
[5] 裴俊文, 孙太振. 丹栀逍遥散合二仙汤治疗乳腺癌内分泌治疗后类更年期综合征[J].中医学报 2019, 34(9):1973-1976.
[6] 中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2015版)[J].中国癌症杂志, 2015, 25(9):692-754.
[7] 裴小静, 杨娜. 对于《中药、天然药物治疗女性更年期综合征临床研究技术指导原则》的考虑和分析[J].中国新药杂志, 2017, 26(18):2193-2195.
[8] 马宝璋. 中医妇科学[M].第2版.北京:中国中医药出版社, 2012:145-147.
[9] 郑筱萸. 中药新药临床研究指导原则[M]. 北京:中国医药科技出版社, 2002:117-119.
[10] 张静, 彭海燕. 补肾养肝法干预乳腺癌内分泌治疗不良反应的研究进展[J].中国中西医结合杂志, 2015, 35(1):124-127.
[11] 李旭, 王浩, 徐红平,等. 激素受体阳性乳腺癌患者在不同内分泌治疗用药时间的类更年期症状及生命质量[J].中华肿瘤杂志, 2020, 42(1):55-60.
[12] 肖苗苗, 刘磊, 易呈浩,等. 促性腺激素释放激素类似物对绝经前乳腺癌化疗患者卵巢功能保护的疗效分析:一项Meta分析[J].肿瘤, 2019, 39(2):40-49.
[13] 张季, 李杨, 杨思原,等. 乳腺癌患者血清神经生长因子和低亲和力受体p75表达水平的变化及其意义[J].中国普通外科杂志, 2017, 26(11):1498-1501.